| Abstract P010 – Table 1. Individuals' characteristics among those fully protected, partially protected and not protected for HAV, HBV or HPV. | |||||
|---|---|---|---|---|---|
| Overall (n = 473) | Not protected (n = 96) | Partially protected (n = 231) | Fully protected (n = 146) | p‐value | |
| Age | 34.6 (30.6 to 39.9) | 33.9 (28.4 to 38.0) | 34.9 (31.1 to 41.1) | 34.9 (30.6 to 39.7) | p = 0.052 |
| Ethnicity | p = 0.054 | ||||
| Asian | 2 (0.42%) | 1 (1.04%) | 0 (0.00%) | 1 (0.68%) | |
| Caucasian | 460 (97.3%) | 91 (94.8%) | 225 (97.4%) | 144 (98.6%) | |
| Hispanic | 6 (1.27%) | 1 (1.04%) | 5 (2.16%) | 0 (0.00%) | |
| Black | 5 (1.06%) | 3 (3.12%) | 1 (0.43%) | 1 (0.68%) | |
| Education | p = 0.784 | ||||
| Middle school | 11 (2.33%) | 2 (2.08%) | 4 (1.73%) | 5 (3.42%) | |
| High school | 164 (34.7%) | 31 (32.3%) | 80 (34.6%) | 53 (36.3%) | |
| University | 298 (63.0%) | 63 (65.6%) | 147 (63.6%) | 88 (60.3%) | |
| Partners | p = 0.193 | ||||
| 0 to 9 | 192 (40.6%) | 33 (34.4%) | 105 (45.5%) | 54 (37.0%) | |
| 10 to 19 | 156 (33.0%) | 41 (42.7%) | 65 (28.1%) | 50 (34.2%) | |
| 20 to 49 | 102 (21.6%) | 19 (19.8%) | 48 (20.8%) | 35 (24.0%) | |
| 50 or more | 23 (4.86%) | 3 (3.12%) | 13 (5.63%) | 7 (4.79%) | |
| Chemsex (Yes) | 222 (46.9%) | 45 (46.9%) | 105 (45.5%) | 72 (49.3%) | p = 0.765 |
| Smith Index | p = 0.026 | ||||
| 10 to 19 | 42 (8.88%) | 6 (6.25%) | 29 (12.6%) | 7 (4.79%) | |
| 20 to 29 | 245 (51.8%) | 44 (45.8%) | 122 (52.8%) | 79 (54.1%) | |
| 30 or more | 186 (39.3%) | 46 (47.9%) | 80 (34.6%) | 60 (41.1%) | |
| Previous STI (Yes) | 249 (52.6%) | 50 (52.1%) | 116 (50.2%) | 83 (56.8%) | p = 0.451 |
| Baseline STI (Yes) | 113 (23.9%) | 15 (15.6%) | 55 (23.8%) | 43 (29.5%) | p = 0.048 |
| PrEP regimen | p = 0.001 | ||||
| Event‐based | 233 (49.3%) | 56 (58.3%) | 124 (53.7%) | 53 (36.3%) | |
| Daily‐based | 240 (50.7%) | 40 (41.7%) | 107 (46.3%) | 93 (63.7%) | |
| Dropout (Yes) | 35 (7.40%) | 9 (9.38%) | 17 (7.36%) | 9 (6.16%) | p = 0.646 |